Podcast
The Plus SideZ: A GLP-1 Guide to Metabolic Health
Hosted by Kim Carlos · EN
Looking for real information on GLP-1 medications and weight loss? You’re in the right place.
The Plus SideZ Podcast is your go-to space for science-backed conversations about obesity treatment, weight loss, and living with a chronic metabolic disorder. Hosted by Kim Carlos and Kat Carter, we explore GLP-1 medications like Ozempic, Wegovy, Mounjaro, and Zepbound, featuring insights from leading obesity specialists, endocrinologists, and bariatric surgeons. But this podcast is about more than just medication—it’s about navigating the mental, emotional, and physical journey of reclaiming your health.
We combat misinformation with education from top experts, helping you think critically about the latest research, treatment options, and systemic challenges in obesity care. And at the heart of it all are the powerful, vulnerable stories of our brave community members—people sharing their real experiences on GLP-1 medications, breaking stigma, and taking control of their health.
Ranked in the top 1% of podcasts globally, The Plus SideZ Podcast has won three awards in just 18 months, including two Anthem Awards for social impact. Featured on Good Morning America, Bloomberg News, and ABC Nightline on Hulu, we’re at the forefront of the conversation on weight loss, obesity care, and the fight to end weight bias.
Join us and be part of a movement that’s changing the way the world understands obesity, health, and metabolic wellness.
Our Linktree
https://linktr.ee/theplussidez
Want to donate?
PayPal
https://www.paypal.com/donate/?hosted_button_id=ZSEE2DRPHDSZN
GoFundMe
https://gofund.me/82c8138e
Shop The Plus SideZ Merch Store
https://the-plus-sidez-podcast.printify.me/products/1
Website
https://theplussidez.com/
43episodes
Episodes
Newest firstAll episodes
GLP-1 NEWS: Access at Risk – What Current Lawsuits and Legislation Mean
Jan 2001:24:48Tap to summarizeLinktree for Community Resourceshttps://linktr.ee/theplussidezpodcast_________________________________________________________________________In this episode, we break down the latest GLP-1 news around policy and legal developments impacting access to compounded GLP-1 medications in the United States.We’re joined by special news correspondents Sabina Henn, an obesity advocate from GLPWinner.com, and Maria Rising, a GLP-1 reporter on TikTok and obesity advocate. Both are deeply involved in obesity care advocacy and work on and off the internet to protect patient access to treatment.We begin with the broader national strategy shaping current GLP-1 policy, then walk through key federal and state actions, including the SAFE Drug Act (SR 6509), Indiana SB 282, and Florida SB 860 / HB 877. We explain how these bills could restrict access to compounded GLP-1 medications and why that poses a serious problem for patients who cannot take brand-name drugs or cannot afford them due to lack of insurance coverage and high costs.We also cover the ongoing lawsuits between GLP-1 drug manufacturers and compounding pharmacies, including the Strive lawsuit, and examine the use of racketeering claims as a legal strategy. Throughout the episode, we focus on the real-world impact of these actions and how they could affect millions of patients relying on compounded GLP-1 medications for obesity and metabolic disease care.We close with clear ways listeners can stay informed, engage, and help protect access to care.Lawsuit Tracker https://docs.google.com/spreadsheets/d/1XoaPEVWv5AxUJyoluaD-eExTPHK3GClIiV0xyI9rXqc/edit?usp=sharingFollow Sabina: Tiktok: https://www.tiktok.com/@lawliepop?lang=enInstagram: https://www.instagram.com/glpwinner/X: https://x.com/lawliepop?lang=enYouTube: https://www.youtube.com/ @lawliepop Follow Maria TikTokhttps://www.tiktok.com/@tirzepatidetales?_r=1&_t=ZP-93ELkA5nG9eSubstack https://substack.com/search/tirzepatidetales?searching=profile_________________________________________________________________________Join this channel to get access to perks:https://www.youtube.com/channel/UC0HUIGKl3BN4Vg6LYI-dkOA/join_________________________________________________________________________#Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide #GLP1 #Obesity #zepbound #wegovy #GLP1NewsSend us Fan Mail! Support the showKim Carlos, Executive Producer TikTok Instagram Kat Carter, Producer TikTok Instagram
Transcribe →GLP-1s, Weight Regain, & Why Men Don’t Seek Help P2
Jan 2001:07:37Tap to summarizeResources for the Community:___________________________________________________________________Podcast Favorite Links!https://linktr.ee/theplussidezFind Your US Representatives https://www.usa.gov/elected-officials ______________________________________________________________________Men with obesity face a significantly higher risk of early death than women with obesity, yet many still avoid doctors, delay care, and see weight struggles as weakness rather than a medical condition.In this episode, community member AJ shares his journey through weight loss, regain, and sustainable progress, opening a deeper conversation about men’s health, obesity as a chronic disease, and the role GLP-1 medications can play in long-term care, not as a shortcut, but as support.We explore why men disengage from healthcare, how fear and shame disguise themselves as toughness, and what real obesity treatment looks like over time. This episode is also for the women who love them, offering language, insight, and practical takeaways to help encourage the men in their lives to seek the care they deserve and believe they are worthy of.Community Guest: AJ Big Boy to Slim BoyTT/IG: ajcook06Expert Guest: Dr. Kevin Gendreau, Obesity Specialist Metabolic Health Handbook: https://a.co/d/fHI2hOkTT/IG: @kevingendreau ______________________________________________________________________Join this channel to get access to perks: YouTube/@theplussidez______________________________________________________________________#Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide #GLP1 #Obesity #zepbound #wegovy #ObesityCare #PatientAdvocate #GLP1Community #RealGLP1StoriesSend us Fan Mail! Support the showKim Carlos, Executive Producer TikTok Instagram Kat Carter, Producer TikTok Instagram
Transcribe →UPDATED AUDIO: GLP-1s, Weight Regain, & Why Men Don’t Seek Help P1
Jan 1501:05:46Tap to summarizeHere is the updated audio of the most recent episode. **Friends, we are so sorry about the audio issues we've had lately. We are implementing new standards to improve audio quality for both ourselves and our guests. We appreciate the kind feedback and the absence of negative reviews. Positive reviews help us grow so we can help people who are lost, lonely, sick, and need education and community. Negative reviews have the opposite effect. Thank you for your patience as we work through these new standards, and thank you for showing us grace. Plus SideZ Favorite Links and Sponsorshttps://linktr.ee/theplussidez ______________________________________________________________________ This isn’t medical advice — always talk to your doctor before making any health decisions.In this episode, community member AJ shares his journey through weight loss, regain, and sustainable progress, opening a deeper conversation about men’s health, obesity as a chronic disease, and the role GLP-1 medications can play in long-term care, not as a shortcut, but as support.Community Guest: AJ Big Boy to Slim BoyTT/IG: ajcook06Expert Guest: Kevin Gendreau, MDMetabolic Health Handbook: https://a.co/d/fHI2hOkTT/IG: @kevingendreau #Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide #GLP1 #Obesity #zepbound #wegovy #ObesityCare #PatientAdvocate #GLP1Community Send us Fan Mail! Support the showKim Carlos, Executive Producer TikTok Instagram Kat Carter, Producer TikTok Instagram
Transcribe →What Causes Obesity? The Biology We Were Never Taught & GLP-1’s Role P1
Dec 1600:52:53Tap to summarizeResources for the Community:___________________________________________________________________https://linktr.ee/theplussidezRo - Telehealth for GLP1 weight management https://ro.co/weight-loss/?utm_source=plussidez&utm_medium=partnership&utm_campaign=comms_yt&utm_content=45497&utm_term=55Find Your US Representatives https://www.usa.gov/elected-officials ______________________________________________________________________ This isn’t medical advice — always talk to your doctor before making any health decisions.In this episode, we discuss the complexities of obesity, moving far beyond the simple "calories in, calories out" narrative. Our conversation unravels the latest science to distinguish between different types of obesities (e.g., metabolically healthy vs. unhealthy, visceral vs. subcutaneous fat distribution), challenging the perception of obesity as a single, uniform condition. Experts in obesity medicine and educators, we examined the landscape of collegiate obesity and nutrition education of future leaders. We dive into how the landscape of obesity treatment is being introduced to new students and practitioners. Our experts contrast modern, holistic, and evidence-based approaches with past didactic methods, emphasizing metabolic health, patient empathy, and anti-bias training.Our astute educators help Debunk GLP-1 Myths as well. A critical segment is dedicated to dismantling the misconception that weight loss on GLP-1 agonists (like Ozempic or Wegovy) is simply due to calorie restriction alone. Our experts explain the drug's mechanisms involving satiety signals, gastric emptying, and metabolic pathways, proving it is a complex hormonal and neurological intervention.Don’t miss this important episode, and learn how the future of obesity treatment is being shaped.Professional Guest:Leah D. Whigham, PhD, FTOSProfessor, Department of Nutritional SciencesDr. Nik DhurandharPaul W. Horn Distinguished ProfessorHelen DeVitt Jones Endowed ChairChair, Department of Nutritional SciencesAssociate Dean for Innovation, College of Health and Human SciencesTexas Tech UniversityCheck out Dr Dhurandhar's Fat-loss Diet book at the below linkhttps://www.amazon.com/Dhurandhars-Fat-loss-Diet-Nikhil-Dhurandhar/dp/9352770307______________________________________________________________________Send us Fan Mail! Support the showKim Carlos, Executive Producer TikTok https://www.tiktok.com/@dmfkim?is_from_webapp=1&sender_device=pc Instagram https://www.instagram.com/dmfkimonmounjaro?igsh=aDF6dnlmbHBoYmJn&utm_source=qr Kat Carter, Associate Producer TikTok https://www.tiktok.com/@katcarter7?is_from_webapp=1&sender_device=pc Instagram https://www.instagram.com/mrskatcarter?utm_source=ig_web_button_share_sheet&igsh=ZDNlZDc0MzIxNw==
Transcribe →Season Finale: GLP-1, Genetics, & Our Family’s Journey
Dec 801:58:19Tap to summarizeIn this special season five finale of The Plus SideZ Podcast, we dive deep into the powerful role of genetics in our weight and health journeys. Kim sits down with her mom and sister to share how all three of them have used GLP-1 medications, uncovering the truth that much of our weight is genetically predetermined. They discuss the personal impact of these treatments, the challenges of access, and the transformations they’ve experienced. Along the way, they reflect on what it’s been like to watch Kim grow into an advocate, a top 1% podcaster, and a social media presence—all while balancing the personal connections that matter most. It’s a fitting close to the season, revealing how much of our journey is written in our genes and how much we’ve learned about what we can and can’t control.Send us Fan Mail! Support the showKim Carlos, Executive Producer TikTok https://www.tiktok.com/@dmfkim?is_from_webapp=1&sender_device=pc Instagram https://www.instagram.com/dmfkimonmounjaro?igsh=aDF6dnlmbHBoYmJn&utm_source=qr Kat Carter, Associate Producer TikTok https://www.tiktok.com/@katcarter7?is_from_webapp=1&sender_device=pc Instagram https://www.instagram.com/mrskatcarter?utm_source=ig_web_button_share_sheet&igsh=ZDNlZDc0MzIxNw==
Transcribe →S5 E23 The Plus SideZ Goes Running!
Dec 101:45:00Tap to summarizeResources for the Community:___________________________________________________________________https://linktr.ee/theplussidezpodcast Ro - Telehealth for GLP1 weight management https://ro.co/weight-loss/?utm_source=plussidez&utm_medium=partnership&utm_campaign=comms_yt&utm_content=45497&utm_term=55Find Your US Representatives https://www.usa.gov/elected-officials ______________________________________________________________________The Plus Sidez steps away from the focus on GLP therapies and obesity treatment and dives into the topic of fitness in a plus-sized body.Sandra Mikulic is an athlete in every sense of the word—a passionate runner, marathoner, and the inspiring force behind Run Your Life magazine (runyourlife.ca). She takes us through her remarkable fitness journey, a story defined not by a scale, but by persistence, joy, and challenging societal norms.She shares with us her love for movement at every size and discusses the brave moment she posted her weight on social media. By labeling herself as "The 250-Pound Runner," she has challenged society's normalized perception that "fit" connotes "thin." She is flipping this connection and truly lives the "Fit Has No Size" mantra.Sandra also launched her own magazine, Run Your Life. It chronicles her journey of running in her forties and how this "later start" influenced her approach to training, motivation, and goal setting compared to younger athletes. Sandra offers a powerful message for individuals in larger bodies, particularly in her age group, who are hesitant to start or who struggle to find joy in fitness.She also opens up about her experience with depression after achieving her magazine launch goal, discussing the complex emotional aftermath that can sometimes follow a major accomplishment.Hear Sandra's incredible story on this episode, as her visibility as a marathoner is actively redefining traditional, often exclusive, perceptions of what a "runner" looks like.______________________________________________________________________⭐️Mounjaro Stanley⭐️griffintumblerco.Etsy.comUse code PODCAST10 for $ OFF______________________________________________________________________Join this channel to get access to perks: Send us Fan Mail! Support the showKim Carlos, Executive Producer TikTok https://www.tiktok.com/@dmfkim?is_from_webapp=1&sender_device=pc Instagram https://www.instagram.com/dmfkimonmounjaro?igsh=aDF6dnlmbHBoYmJn&utm_source=qr Kat Carter, Associate Producer TikTok https://www.tiktok.com/@katcarter7?is_from_webapp=1&sender_device=pc Instagram https://www.instagram.com/mrskatcarter?utm_source=ig_web_button_share_sheet&igsh=ZDNlZDc0MzIxNw==
Transcribe →Inside a Retatrutide Clinical Trial Experience: GLP-1s, HRT & Menopause Part 2
Nov 2501:05:13Tap to summarizeResources for the Community:___________________________________________________________________https://linktr.ee/theplussidezpodcast Ro - Telehealth for GLP1 weight management https://ro.co/weight-loss/?utm_source=plussidez&utm_medium=partnership&utm_campaign=comms_yt&utm_content=45497&utm_term=55Find Your US Representatives https://www.usa.gov/elected-officials ______________________________________________________________________We open with community member MiMi, who shares her experience participating in an Eli Lilly Retatrutide clinical trial, offering a rare, real-world look at this next-generation triple-agonist research. From there, we dive into how menopause and perimenopause reshape metabolism with insight from Dr. Komal Patil-Sisodia, an endocrinologist, obesity-medicine specialist, and midlife menopause expert. We explore how HRT and GLP-1 medications support symptoms, weight, and long-term health, what early research suggests about combining them, and why bone density, TMJ, and diabetes risk all matter in midlife care.Follow Mimimimi_in_australiaFollow Dr. Patil drpatilsisodia______________________________________________________________________⭐️Mounjaro Stanley⭐️griffintumblerco.Etsy.comUse code PODCAST10 for $ OFF______________________________________________________________________Join this channel to get access to perks: / @theplussidez______________________________________________________________________#Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide #GLP1 #Obesity #zepbound #wegovy #ObesityCare #PatientAdvocate #GLP1Community #RealGLP1StoriesSend us Fan Mail! Support the showKim Carlos, Executive Producer TikTok https://www.tiktok.com/@dmfkim?is_from_webapp=1&sender_device=pc Instagram https://www.instagram.com/dmfkimonmounjaro?igsh=aDF6dnlmbHBoYmJn&utm_source=qr Kat Carter, Associate Producer TikTok https://www.tiktok.com/@katcarter7?is_from_webapp=1&sender_device=pc Instagram https://www.instagram.com/mrskatcarter?utm_source=ig_web_button_share_sheet&igsh=ZDNlZDc0MzIxNw==
Transcribe →Inside a Retatrutide Clinical Trial Experience: GLP-1s, HRT & Menopause Part 1
Nov 1800:58:00Tap to summarizeResources for the Community:___________________________________________________________________https://linktr.ee/theplussidezpodcast Ro - Telehealth for GLP1 weight management https://ro.co/weight-loss/?utm_source=plussidez&utm_medium=partnership&utm_campaign=comms_yt&utm_content=45497&utm_term=55Find Your US Representatives https://www.usa.gov/elected-officials ______________________________________________________________________We open with community member MiMi, who shares her experience participating in an Eli Lilly Retatrutide clinical trial, offering a rare, real-world look at this next-generation triple-agonist research. From there, we dive into how menopause and perimenopause reshape metabolism with insight from Dr. Komal Patil-Sisodia, an endocrinologist, obesity-medicine specialist, and midlife menopause expert. We explore how HRT and GLP-1 medications support symptoms, weight, and long-term health, what early research suggests about combining them, and why bone density, TMJ, and diabetes risk all matter in midlife care.Follow Mimimimi_in_australiaFollow Dr. Patil drpatilsisodia______________________________________________________________________⭐️Mounjaro Stanley⭐️griffintumblerco.Etsy.comUse code PODCAST10 for $ OFF______________________________________________________________________Join this channel to get access to perks: / @theplussidez______________________________________________________________________#Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide #GLP1 #Obesity #zepbound #wegovy #ObesityCare #PatientAdvocate #GLP1Community #RealGLP1StoriesSend us Fan Mail! Support the showKim Carlos, Executive Producer TikTok https://www.tiktok.com/@dmfkim?is_from_webapp=1&sender_device=pc Instagram https://www.instagram.com/dmfkimonmounjaro?igsh=aDF6dnlmbHBoYmJn&utm_source=qr Kat Carter, Associate Producer TikTok https://www.tiktok.com/@katcarter7?is_from_webapp=1&sender_device=pc Instagram https://www.instagram.com/mrskatcarter?utm_source=ig_web_button_share_sheet&igsh=ZDNlZDc0MzIxNw==
Transcribe →GLP-1’s at ObesityWeek: Medicare News, New Medications, and Advocacy Insights
Nov 1102:14:20Tap to summarizeResources for the Community:___________________________________________________________________https://linktr.ee/theplussidezpodcast Ro - Telehealth for GLP1 weight management https://ro.co/weight-loss/?utm_source=plussidez&utm_medium=partnership&utm_campaign=comms_yt&utm_content=45497&utm_term=55Find Your US Representatives https://www.usa.gov/elected-officials ______________________________________________________________________Join Our Special Obesity Week Recap Live!We’re hosting a must-watch live event on YouTube featuring top obesity care advocates to break down everything we learned from ObesityWeek and to dive into the future of GLP-1 medications for obesity treatment in America.What to Expect:Expert Advocates & Guests: We’ll be joined by Mike (Mike On A Mission), Zach Niemiec, Amanda from the GLP-1 Collective, along with myself and Kat Carter.In-Depth Discussions: We’ll cover current and upcoming GLP-1 treatments, insights on future insurance coverage, and the latest news on Medicare and Medicaid changes stemming from recent policy shifts.Stay Informed and Engaged: This live is packed with valuable updates for anyone interested in the evolving landscape of obesity care.Watch the Zepbound Emerson Experience https://zepbound.lilly.com/changing-the-threadConnect with our guest hosts Help Zach get skin removal surgery by buying a shirt https://www.bonfire.com/store/glp-1-shirts/?utm_source=linktree&utm_medium=store_widget&utm_campaign=GLP-1%20Shirts&utm_content=store_linkFollow Zack on TikTok https://www.tiktok.com/@lucky_finz?_r=1&_t=ZP-91L3rdS0oNaMike on a mission tohttps://www.tiktok.com/@mike.onamission2?_r=1&_t=ZP-91L3zoJ4U8chttps://mikeonamission2.substack.com/https://www.obesityaction.org/?gad_source=1&gad_campaignid=22668337389&gbraid=0AAAAADooL-H77YwC0nHuWrvy8uCDJRI-oSend us Fan Mail! Support the showKim Carlos, Executive Producer TikTok https://www.tiktok.com/@dmfkim?is_from_webapp=1&sender_device=pc Instagram https://www.instagram.com/dmfkimonmounjaro?igsh=aDF6dnlmbHBoYmJn&utm_source=qr Kat Carter, Associate Producer TikTok https://www.tiktok.com/@katcarter7?is_from_webapp=1&sender_device=pc Instagram https://www.instagram.com/mrskatcarter?utm_source=ig_web_button_share_sheet&igsh=ZDNlZDc0MzIxNw==
Transcribe →GLP-1 Wars: Obesity Week Highlights, Novo Nordisk vs. Pfizer, and Addiction Breakthroughs
Nov 301:32:07Tap to summarizeResources for the Community:___________________________________________________________________https://linktr.ee/theplussidezpodcast Ro - Telehealth for GLP1 weight management https://ro.co/weight-loss/?utm_source=plussidez&utm_medium=partnership&utm_campaign=comms_yt&utm_content=45497&utm_term=55Find Your US Representatives https://www.usa.gov/elected-officials ______________________________________________________________________Get the latest buzz on GLP-1 therapies and the future of metabolic medicine! This episode provides an in-depth look at what's coming out of Obesity Week in Atlanta, GA, featuring expert insights from Dave Knapp from On the Pen.Key Topics & Breakthroughs:Corporate Battle for Biotech: We break down the surprise counteroffer by Novo Nordisk to acquire Metsera, the obesity biotech company that Pfizer had recently announced it was buying, setting the stage for a major pharmaceutical turf war.Pipeline Watch: Dive into the plethora of new therapies in current clinical trials, including the latest developments from Viking Therapeutics and the push for Oral GLP-1s.GLP-1's New Frontier: Discover the groundbreaking research on GLP-1's potential role in treating alcohol and narcotics addictions. We also discuss Brenipatide and its surprising dual focus on alcohol abuse and asthma.Tune in for a comprehensive review of the medications, mergers, and clinical trials shaping the next generation of weight loss and metabolic treatments.______________________________________________________________________⭐️Mounjaro Stanley⭐️griffintumblerco.Etsy.comUse code PODCAST10 for $ OFF______________________________________________________________________Join this channel to get access to perks: / @theplussidez______________________________________________________________________#Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide #GLP1 #Obesity #zepbound #wegovy #ObesityCare #PatientAdvocate #GLP1Community #RealGLP1StoriesSend us Fan Mail! Support the showKim Carlos, Executive Producer TikTok https://www.tiktok.com/@dmfkim?is_from_webapp=1&sender_device=pc Instagram https://www.instagram.com/dmfkimonmounjaro?igsh=aDF6dnlmbHBoYmJn&utm_source=qr Kat Carter, Associate Producer TikTok https://www.tiktok.com/@katcarter7?is_from_webapp=1&sender_device=pc Instagram https://www.instagram.com/mrskatcarter?utm_source=ig_web_button_share_sheet&igsh=ZDNlZDc0MzIxNw==
Transcribe →